Balyasny Asset Management’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,176,916
Closed -$96.3M 3431
2022
Q2
$96.3M Buy
4,176,916
+3,130,418
+299% +$73.1M 0.31% 48
2022
Q1
$22.8M Sell
1,046,498
-738,482
-41% -$15.3M 0.07% 373
2021
Q4
$38.2M Buy
1,784,980
+1,086,926
+156% +$22.8M 0.13% 206
2021
Q3
$14.6M Buy
698,054
+549,050
+368% +$12M 0.06% 430
2021
Q2
$3.43M Buy
149,004
+45,500
+44% +$1.05M 0.02% 835
2021
Q1
$2.29M Buy
+103,504
New +$2.4M 0.01% 981
2020
Q4
Sell
-202,413
Closed -$2.94M 1820
2020
Q3
$2.94M Buy
202,413
+102,720
+103% +$1.31M 0.02% 734
2020
Q2
$1.12M Sell
99,693
-81,978
-45% -$921K 0.01% 809
2020
Q1
$1.81M Buy
+181,671
New +$2.54M 0.02% 633
2019
Q4
Sell
-406,028
Closed -$4.91M 1578
2019
Q3
$4.91M Buy
406,028
+221,528
+120% +$3.04M 0.03% 552
2019
Q2
$2.69M Buy
+184,500
New +$2.73M 0.02% 794

Other funds holding CHNG

Balyasny Asset Management's CHNG Position: Q3 2022 in Review

Balyasny Asset Management sold out of Change Healthcare Inc. Common Stock (CHNG) in Q3 2022, closing a stake of 4,176,916 shares — an estimated $96.3M sold.

Balyasny Asset Management first reported a position in CHNG in Q2 2019 and held it in 11 quarters. The position peaked at $96.3M in Q2 2022. 263 funds tracked by Wall St. Rank hold CHNG as of Q3 2022.

  • Balyasny Asset Management reported no remaining Change Healthcare Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 4,176,916 Change Healthcare Inc. Common Stock shares in Q3 2022, an estimated $96.3M.
  • Balyasny Asset Management first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 11 quarters.
  • Balyasny Asset Management's Change Healthcare Inc. Common Stock position peaked at $96.3M in Q2 2022.
  • 263 funds tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.